Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Macy's, Inc. stock logo
M
Macy's
$23.80
-4.4%
$23.31
$16.69
▼
$26.58
$6.21B1.396.41 million shs5.65 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$27.57
-1.8%
$28.83
$23.62
▼
$31.44
$157.12B0.3139.69 million shs35.48 million shs
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Macy's, Inc. stock logo
M
Macy's
+6.14%-0.25%+5.37%+10.02%+27.43%
Pfizer Inc. stock logo
PFE
Pfizer
-1.23%-4.63%-4.74%+0.81%+10.24%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Macy's, Inc. stock logo
M
Macy's
$23.80
-4.4%
$23.31
$16.69
▼
$26.58
$6.21B1.396.41 million shs5.65 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$27.57
-1.8%
$28.83
$23.62
▼
$31.44
$157.12B0.3139.69 million shs35.48 million shs
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Macy's, Inc. stock logo
M
Macy's
+6.14%-0.25%+5.37%+10.02%+27.43%
Pfizer Inc. stock logo
PFE
Pfizer
-1.23%-4.63%-4.74%+0.81%+10.24%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Macy's, Inc. stock logo
M
Macy's
2.08
Hold$22.78-4.27% Downside
Pfizer Inc. stock logo
PFE
Pfizer
2.18
Hold$30.329.98% Upside

Current Analyst Ratings Breakdown

Latest M and PFE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/12/2026
Pfizer Inc. stock logo
PFE
Pfizer
Reiterated RatingMarket Perform$29.00
11/9/2026
Pfizer Inc. stock logo
PFE
Pfizer
UpgradeHold (C) ➝ Hold (C+)
11/6/2026
Pfizer Inc. stock logo
PFE
Pfizer
Set Price Target$34.00
11/6/2026
Pfizer Inc. stock logo
PFE
Pfizer
Boost Price TargetBuy$33.00 ➝ $34.00
11/6/2026
Pfizer Inc. stock logo
PFE
Pfizer
DowngradeBuy ➝ Hold
11/5/2026
Pfizer Inc. stock logo
PFE
Pfizer
Boost Price TargetBuy$31.00 ➝ $33.00
11/4/2026
Pfizer Inc. stock logo
PFE
Pfizer
Set Price Target$40.00
11/4/2026
Pfizer Inc. stock logo
PFE
Pfizer
Boost Price TargetNeutral$27.00 ➝ $30.00
11/4/2026
Pfizer Inc. stock logo
PFE
Pfizer
Boost Price TargetSector Outperform$33.00 ➝ $35.00
11/4/2026
Pfizer Inc. stock logo
PFE
Pfizer
Boost Price TargetNeutral$27.00 ➝ $30.00
10/30/2026
Macy's, Inc. stock logo
M
Macy's
Initiated CoverageHold
(Data available from 11/19/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Macy's, Inc. stock logo
M
Macy's
$22.62B0.27$5.90 per share4.03$18.28 per share1.30
Pfizer Inc. stock logo
PFE
Pfizer
$63.63B2.47$4.25 per share6.48$15.67 per share1.76
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Macy's, Inc. stock logo
M
Macy's
$642M$2.738.729.75N/A3.29%13.21%3.83%12/2/2026 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$7.77B$0.7039.389.311.876.34%19.88%8.52%2/2/2027 (Estimated)

Latest M and PFE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
12/2/2026Q3 2026
Macy's, Inc. stock logo
M
Macy's
-$0.1805N/AN/AN/A$4.68 billionN/A
11/3/2026Q3 2026
Pfizer Inc. stock logo
PFE
Pfizer
$0.7350$0.87+$0.1350$0.56$15.85 billion$16.58 billion
9/10/2026Q2 2026
Macy's, Inc. stock logo
M
Macy's
$0.3706$0.63+$0.2594$0.62$4.81 billion$5.06 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Macy's, Inc. stock logo
M
Macy's
$0.773.24%+13.95%28.21%4 Years
Pfizer Inc. stock logo
PFE
Pfizer
$1.726.24%-13.20%245.71%16 Years

Latest M and PFE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
10/23/2026
Macy's, Inc. stock logo
M
Macy's
quarterly$0.19153.18%12/15/202612/15/20261/4/2027
10/6/2026
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.435.85%11/6/202611/6/202612/7/2026
8/28/2026
Macy's, Inc. stock logo
M
Macy's
quarterly$0.19153.48%9/15/20269/15/202610/1/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Macy's, Inc. stock logo
M
Macy's
0.49
1.59
0.48
Pfizer Inc. stock logo
PFE
Pfizer
0.67
1.42
1.10

Institutional Ownership

CompanyInstitutional Ownership
Macy's, Inc. stock logo
M
Macy's
87.36%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%

Insider Ownership

CompanyInsider Ownership
Macy's, Inc. stock logo
M
Macy's
1.05%
Pfizer Inc. stock logo
PFE
Pfizer
0.62%
CompanyEmployeesShares OutstandingFree FloatOptionable
Macy's, Inc. stock logo
M
Macy's
90,134261.18 million258.44 millionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
75,0005.70 billion5.66 billionOptionable

Recent News About These Companies

Pfizer inks $2.6bn autoimmune deal with China’s Starna for CAR-T therapies
Pfizer (NYSE:PFE) Stock Falls 1.5% - What's Next?
Pfizer inks cell therapy licensing deal with Starna worth up to $2.6B
Pfizer leaps into ‘in vivo’ CAR-T with latest China deal
Pfizer: The Patent Cliff Fears Are Overblown
Leerink Partners Keeps Their Hold Rating on Pfizer (PFE)
Pfizer pays $330 million for Starna's CAR-T programs
Pfizer, Starna ink cell therapy licensing deal worth up to $2.6B

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Macy's stock logo

Macy's NYSE:M

$23.80 -1.09 (-4.36%)
Closing price 03:59 PM Eastern
Extended Trading
$23.78 -0.01 (-0.04%)
As of 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Macy's, Inc. engages in the retail of apparel, accessories, cosmetics, home furnishings, and other consumer goods. The firm's brands include Macy's, Bloomingdale's, and Bluemercury. It offers men's, women's, and children's apparel, women's accessories, intimate apparel, shoes, cosmetics, fragrances, as well as home and miscellaneous products. The company was founded by Rowland H. Macy in 1858 and is headquartered in New York, NY.

Pfizer stock logo

Pfizer NYSE:PFE

$27.56 -0.50 (-1.76%)
Closing price 03:59 PM Eastern
Extended Trading
$27.54 -0.03 (-0.09%)
As of 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.